Human early mesenchymal stromal cells delivered on porous lightweight biodegradable polycaprolactone-based microcarriers result in improved cartilage formation

التفاصيل البيبلوغرافية
العنوان: Human early mesenchymal stromal cells delivered on porous lightweight biodegradable polycaprolactone-based microcarriers result in improved cartilage formation
المؤلفون: Eileen Sim, Youshan Melissa Lin, Jialing Lee, James Hoi Po Hui, Shaul Reuveny, William R. Birch, Mahesh Choolani, Teo Kim Leng, A. Lam, Steve Oh, Jerry Kok Yen Chan, Li Jian, Jessica Pei Wen Toh, Xiafei Ren, Barry Wl Tan
المصدر: Materialia. 13:100851
بيانات النشر: Elsevier BV, 2020.
سنة النشر: 2020
مصطلحات موضوعية: 010302 applied physics, Confluency, Materials science, Cartilage, Mesenchymal stem cell, Microcarrier, 02 engineering and technology, Bone healing, 021001 nanoscience & nanotechnology, Chondrogenesis, 01 natural sciences, chemistry.chemical_compound, medicine.anatomical_structure, chemistry, In vivo, 0103 physical sciences, Polycaprolactone, medicine, General Materials Science, 0210 nano-technology, Biomedical engineering
الوصف: Porous lightweight polycaprolactone (LPCL)-based microcarriers (MC) can be used for large-scale production of human mesenchymal stromal cells (MSC) in stirred bioreactors. These biodegradable MC can serve in delivering MSC, which exhibit improved bone healing in a rat calvarial defect model. Therefore, this study aims to explore their use as scaffolds to create chondrogenically differentiated, MSC-laden LPCL MC constructs for cartilage formation in vitro and in vivo in a rabbit osteochondral defect model. In-vitro studies, defining critical parameters that resulted in efficient chondrogenic differentiation of MSC expanded on the surface of LPCL MC were performed. The optimized MSC-LPCL MC constructs were transplanted in a rabbit osteochondral defect model and evaluated after 5 months, with histological staining and scoring. Our in vitro studies demonstrate that about 4.7 × 103 porous LPCL MC seeded with 50 × 103 cells at early exponential growth phase (21% cell confluency) resulted in the best MSC-PCL MC construct, with efficient cell growth and chondrogenic differentiation, after 21 days. Implantation of chondrogenically differentiated MSC-LPCL MC constructs resulted in the best cartilage healing outcomes: (i) 75% of samples (6 out 8 defects) displaying good healing outcomes, (ii) the greatest histological score at 22 ± 7 and 26 ± 7 (without and with subchondral bone evaluation respectively), and (iii) the highest mean score for 8 out of 12 categories, as compared to other transplant groups. This is the first study demonstrating that chondrogenically differentiated MSC-LPCL MC constructs can induce the most efficient cartilage healing in rabbits with an osteochondral defect.
تدمد: 2589-1529
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::244fb6cc8295f6061f935d74efc57a87
https://doi.org/10.1016/j.mtla.2020.100851
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........244fb6cc8295f6061f935d74efc57a87
قاعدة البيانات: OpenAIRE